KBC Group’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50K Hold
6,462
– – ﹤0.01% 1719
2026
Q2
$63K Hold
6,462
– – ﹤0.01% 1636
2026
Q1
$55K Hold
6,462
– – ﹤0.01% 1619
2025
Q4
$78K Buy
+6,462
New +$78.5K ﹤0.01% 1448

Other funds holding OCUL

KBC Group's OCUL Position: Q3 2026 in Review

KBC Group held its Ocular Therapeutix (OCUL) position steady in Q3 2026 at 6,462 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

KBC Group first reported a position in OCUL in Q4 2025 and has held it in 4 quarters since. The position peaked at $78K in Q4 2025. 263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • KBC Group held 6,462 shares of Ocular Therapeutix worth $50K as of Q3 2026.
  • KBC Group left its Ocular Therapeutix share count unchanged in Q3 2026.
  • Ocular Therapeutix made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1719 holding.
  • KBC Group first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 4 quarters since.
  • KBC Group's Ocular Therapeutix position peaked at $78K in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.